59-Year-Old Man With Relapsed Follicular Lymphoma

Jonathan Friedberg, MD, describes a patient case and his initial impressions looking at the typical and atypical presentation of follicular lymphoma and the risk of transformation, bulky disease, presence of symptoms, and FLIPI score.
For more resources and information regarding anticancer targeted therapies: targetedonc.com/

[@DoubleGauss]

Don't leave out bispecific antibodies like Regn1979, that could well be crowned the new king of FL treatment.